Inventor
MÜNZ MARKUS
DE6 patents
Patents
6 patentsUS10301391B2May 28, 2019
BCMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH28 citations93
US10781264B2Sep 22, 2020
PSMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH8 citations82
US11661462B2May 30, 2023
Optimized cross-species specific bispecific single chain antibody contructs
AMGEN RES MUNICH GMBH4 citations73
US11434302B2Sep 6, 2022
Bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH7 citations73
US11352433B2Jun 7, 2022
BCMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH2 citations71
US12428491B2Sep 30, 2025
PSMA and CD3 bispecific T cell engaging antibody constructs
AMGEN RES MUNICH GMBH0 citations61